(Q34637331)

3 August 2017

1 reference

title

Pathogenesis of bone lesions in rheumatoid arthritis (English)

1 reference

3 August 2017

1 reference

1

Steven R Goldring

1 reference

3 August 2017

2

Ellen M Gravallese

1 reference

3 August 2017

publication date

1 June 2002

1 reference

Current Rheumatology Reports

3 August 2017

published in

1 reference

3 August 2017

volume

4

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

226-231

1 reference

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11926-002-0069-Y

Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-002-0069-Y

Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-002-0069-Y

TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-002-0069-Y

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

21 January 2018

1 reference

12 December 2020

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

12 December 2020

Factors predicting outcome of rheumatoid arthritis: results of a followup study

1 reference

12 December 2020

Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis

1 reference

12 December 2020

Osteoclast-like cells in an in vitro model of bone destruction by rheumatoid synovium.

1 reference

12 December 2020

Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients

1 reference

12 December 2020

Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis

1 reference

12 December 2020

Cytokines in the pathogenesis of osteoporosis

1 reference

12 December 2020

Generation of osteoclastic function in mouse bone marrow cultures: multinuclearity and tartrate-resistant acid phosphatase are unreliable markers for osteoclastic differentiation.

1 reference

12 December 2020

Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint

1 reference

12 December 2020

T Cell Activation Induces Human Osteoclast Formation via Receptor Activator of Nuclear Factor κB Ligand-Dependent and -Independent Mechanisms

1 reference

12 December 2020

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

1 reference

12 December 2020

Osteoclast-like cells in murine collagen induced arthritis

1 reference

12 December 2020

A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis

1 reference

12 December 2020

IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis

1 reference

12 December 2020

The role of cytokines in the pathogenesis of rheumatoid arthritis

1 reference

12 December 2020

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

1 reference

12 December 2020

Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover.

1 reference

12 December 2020

From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins

1 reference

12 December 2020

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

12 December 2020

IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.

1 reference

12 December 2020

Organ-specific disease provoked by systemic autoimmunity

1 reference

12 December 2020

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

12 December 2020

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

12 December 2020

NE-58095: a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis

1 reference

12 December 2020

Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction.

1 reference

12 December 2020

Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion

1 reference

12 December 2020

Activated T lymphocytes support osteoclast formation in vitro

1 reference

12 December 2020

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

12 December 2020

Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice

1 reference

12 December 2020

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist

1 reference

12 December 2020

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

1 reference

12 December 2020

Intranasal calcitonin for the prevention of bone erosion and bone loss in rheumatoid arthritis

1 reference

12 December 2020

The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: A controlled magnetic resonance imaging study

1 reference

12 December 2020

Zoledronate (CGP 42'446), a bisphosphonate, protects against metaphyseal intracortical defects in experimental inflammatory arthritis

1 reference

12 December 2020

Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group

1 reference

12 December 2020

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

1 reference

12 December 2020

Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a three-year randomized, double-blind trial

1 reference

12 December 2020

Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis

1 reference

12 December 2020

Effect of calcitonin on bone histomorphometry and bone metabolism in rheumatoid arthritis

1 reference

12 December 2020

Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme

1 reference

12 December 2020

The erosive front: a topographic study of the junction between the pannus and the subchondral plate in the macerated rheumatoid metacarpal head

1 reference

12 December 2020

RANK is essential for osteoclast and lymph node development

1 reference

12 December 2020

The human osteoclast precursor circulates in the monocyte fraction

1 reference

12 December 2020

Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor

1 reference

12 December 2020

Bone resorption by tartrate-resistant acid phosphatase-positive multinuclear cells isolated from rheumatoid synovium

1 reference

12 December 2020

Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis

1 reference

12 December 2020

Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis

1 reference

12 December 2020

Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint.

1 reference

12 December 2020

Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium

1 reference

12 December 2020

Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin

1 reference

12 December 2020

Parathyroid hormone-related peptide in synovial fluid and disease activity of rheumatoid arthritis

1 reference

12 December 2020

A novel role of IL-15 in the development of osteoclasts: inability to replace its activity with IL-2

1 reference

12 December 2020

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

12 December 2020

Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis

1 reference

12 December 2020

The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease

1 reference

12 December 2020

Failure of cells of the mononuclear phagocyte series to resorb bone

1 reference

12 December 2020

Bone resorption by cells isolated from rheumatoid synovium

1 reference

12 December 2020

10.1007/S11926-002-0069-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1019883328

0 references

1 reference